What specific financial results are disclosed in this 8-K filing?

This 8-K filing does not contain the specific financial results within its text. Instead, it serves as a notification that Medtronic's third quarter fiscal year 2020 financial results have been released and are available in the accompanying press release furnished as Exhibit 99.1.

Where can I find the detailed financial performance for Medtronic's third quarter FY2020?

The detailed financial performance, including revenue, earnings per share, and segment-specific data for Medtronic's third quarter of fiscal year 2020, can be found in the press release that is furnished as Exhibit 99.1 to this 8-K filing.

What is the significance of filing an 8-K with an attached press release?

Filing an 8-K is a requirement for publicly traded companies to announce significant events, such as the release of financial results. Attaching the press release as an exhibit ensures that the detailed financial information is officially filed with the SEC and readily accessible to investors and the public.

Does this filing contain any forward-looking statements or guidance from Medtronic?

Forward-looking statements and any financial guidance for future periods would typically be included in the press release (Exhibit 99.1) that accompanies this 8-K filing, rather than in the 8-K itself.

MDT 8-K: Earnings & Results

Summary

Medtronic plc (MDT) filed an 8-K on February 18, 2020, to announce its third quarter fiscal year 2020 financial results. While the 8-K itself is a procedural filing, it incorporates by reference a press release (Exhibit 99.1) containing the actual financial performance details. Investors should refer to this press release for a comprehensive understanding of the company's performance during the quarter ended February 17, 2020, including key metrics such as revenue, earnings per share, and segment performance. The primary takeaway for investors from this filing is the disclosure of Q3 FY2020 financial results. The 8-K serves as the official notification mechanism for these results, directing stakeholders to the detailed information provided in the accompanying press release. Any significant financial achievements, challenges, or forward-looking statements made by Medtronic for the third quarter would be found within that press release, offering crucial insights into the company's operational health and market position.

Key Highlights

1Medtronic filed an 8-K on February 18, 2020, to report its third quarter fiscal year 2020 financial results.
2The filing incorporates a press release (Exhibit 99.1) as the primary source of detailed financial information for the quarter.
3The results pertain to the quarter ended February 17, 2020.
4Investors should consult the furnished press release for specific financial performance data.
5This 8-K serves as the formal announcement and reference point for MDT's Q3 FY2020 earnings.
6No other material events or business updates are detailed within the 8-K filing itself.

Medtronic plc 8-K Report, Financial Results (Feb 18, 2020)

Summary

Key Highlights

Frequently Asked Questions